Nuclear Medicine: Page 14

Novartis struggles to meet Lu-177 demand

By AuntMinnie.com staff writers

Novartis said it is experiencing supply chain challenges for its lutetium-177 (Lu-177) prostate-specific membrane antigen-617 radiopharmaceutical treatment for prostate cancer patients.

March 14, 2023

European companies to develop strategies for dismantling old cyclotrons

By AuntMinnie.com staff writers

A group of European companies plans to develop "turnkey" options for dismantling aging cyclotrons, according to an article in the Brussels Times.

March 9, 2023

SPECT/CT superior to SPECT alone for imaging cardiac amyloidosis

By Will Morton

SPECT/CT fusion imaging offers significant advantages over SPECT alone for imaging cardiac amyloidosis by reducing false positives, according to a study published March 1 in the Journal of Nuclear Cardiology.

March 9, 2023

NorthStar installs accelerator at its new Wisc. facility

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes has installed an electron beam accelerator for the commercial production of Actinium-225 (Ac-225) at its new facility in Beloit, WI.

March 7, 2023

FIND Act reintroduced in Congress

By AuntMinnie.com staff writers

The Facilitating Innovative Nuclear Diagnostic (FIND) Act -- a bill that could significantly change how PET radiopharmaceuticals are covered for Medicare beneficiaries -- has been reintroduced in the U.S. Congress.

March 6, 2023

GE HealthCare completes recruitment for contrast development

By AuntMinnie.com staff writers

GE HealthCare has announced the completion of phase I subject recruitment for the development of a first-of-its-kind manganese-based macrocyclic MRI contrast agent.

February 28, 2023

GE HealthCare close to completing safety recall

By Amerigo Allegretto

GE HealthCare has nearly completed its previously announced safety recall of the company's 600 and 800 series nuclear medicine systems.

February 23, 2023

GE HealthCare recalls certain nuclear medicine systems

By Amerigo Allegretto

GE HealthCare is recalling its 600 and 800 Series nuclear medicine systems after identifying an issue with two safety mechanisms that could potentially lead to a "catastrophic fall" of a detector and potentially trap or crush patients.

February 15, 2023

IsoRay completes merger with Viewpoint Molecular Targeting

By AuntMinnie.com staff writers

Medical isotope developer IsoRay has completed its merger with Viewpoint Molecular Targeting. The deal closed on February 3.

February 5, 2023

Russia breaks ground on nuclear isotope plant

By AuntMinnie.com staff writers

Russian state nuclear energy firm Rosatom has begun construction of a $129 million nuclear research reactor for medical isotope production in Obninsk, a city in the country's Kaluga region, according to Russian media outlets.

January 29, 2023

Siemens secures Health Canada clearance for SPECT/CT system

By AuntMinnie.com staff writers

Siemens Healthineers has received Health Canada clearance for its Symbia Pro.specta SPECT/CT system.

January 22, 2023

NorthStar produces first Mo-99 batch at new facility

By AuntMinnie.com staff writers

NorthStar Medical Isotopes has produced the first batch of molybdenum-99 (Mo-99) at its recently completed therapeutic radioisotope production facility in Beloit, WI.

January 10, 2023

Previous Page

Page 14 of 438

Next Page